Back

Losartan Vs Nebivolol Vs the association of both on the progression of aortic root dilation in genotyped Marfan Syndrome: 48 months open label randomized controlled phase III trial

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Diseases of the aorta: predictors of events and risk modifiers Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Alessandro Di Toro

Foundation IRCCS Policlinic San Matteo - University of Pavia, Pavia (Italy)

4 More presentations in this session

Presentation thumbnail
Aorta and sports. the silent threat
Doctor G. Diaz Babio (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
High wall shear stress predicts plaque rupture of the aortic arch: computational fluid dynamics model and non-obstructive general angioscopy study
Doctor K. Kojima (Tokyo, JP)
Abstract
Presentation thumbnail
Peripheral aneurysms in Marfan patients are common and are related to age and advanced aortic disease.
Doctor G. Teixido Tura (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Maternal, fetal and obstetric outcome in patients with thoracic aortic disease: an ancillary analysis of the ROPAC registry
Doctor L. Campens (Gent, BE)
Abstract

Access the full session

Session thumbnail
Diseases of the aorta: predictors of events and risk modifiers

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources